10-Q//Quarterly update
ImmunoBiotics, Inc. 10-Q
Accession 0001213900-09-003366
CIK 0001413579operating
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:29 PM ET
Size
530.9 KB
Accession
0001213900-09-003366
Documents
- 10-Qf10q0909_immuno.htmPrimary
QUARTERLY REPORT FOR THE PERIOD ENDING 09/09
- EX-31.1f10q0909ex31i_immuno.htm
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
- EX-31.2f10q0909ex31ii_immuno.htm
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
- EX-32.1f10q0909ex32i_immuno.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
- EX-32.2f10q0909ex32ii_immuno.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
Issuer
ImmunoBiotics, Inc.
CIK 0001413579
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001413579
Filing Metadata
- Form type
- 10-Q
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:29 PM ET
- Size
- 530.9 KB